Quantum BioPharma Ltd. Announces Warrant Expiration and Special Dividend Record Date

Quantum BioPharma Ltd. has announced the expiration of all warrants held by hedge funds, marking the final tranche of warrants issued in a previous financing. The company also reiterated October 27, 2025, as the record date for the distribution of contingent value rights (CVRs) to Class B Subordinate Voting Shareholders. These CVRs entitle holders to a pro rata portion of net proceeds from the company's litigation against CIBC World Markets, RBC Dominion Securities, and others, which alleges stock price manipulation and seeks damages exceeding $700 million. Payments under the CVRs are contingent upon the company receiving net proceeds from the litigation, with no guarantee of any payment. The CVRs are non-transferable, non-assignable, and will not carry interest or voting rights.